Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-15

Clinical Trial Update: Iloprost Power Disc-15 in Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 study of Iloprost Power Disc-15 for pulmonary arterial hypertension was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloprost Power Disc-15 (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2013-02-15